FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of FibroGen Inc.
FibroGen Inc business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of FibroGen Inc are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of FibroGen Inc , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of FibroGen Inc including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of FibroGen Inc and all latest updates of the company are provided.
The 2025 version of FibroGen Inc report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 FibroGen Inc- Key Facts
2.2 FibroGen Inc- Geographic Locations
2.3 FibroGen Inc- Subsidiaries and Affiliates
2.4 FibroGen Inc- Business Divisions
2.5 FibroGen Inc- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. FibroGen Inc Strategic Analysis Review
3.1 FibroGen Inc- Key Strategies
3.2 FibroGen Inc- Company Outlook Statement
3.3 FibroGen Inc- SWOT Analysis
3.3.1 FibroGen Inc- Key Strengths
3.3.2 FibroGen Inc- Key Weaknesses
3.3.3 FibroGen Inc- Potential Opportunities
3.3.4 FibroGen Inc- Potential Threats
3.4 FibroGen Inc- Key Competitors
4. Business Description of the Company
4.1 FibroGen Inc- Business Overview
4.2 FibroGen Inc- Operations by Segment
5 Products and Services Details
5.1 FibroGen Inc- Key Products
5.2 FibroGen Inc- Key Service Areas
5.3 FibroGen Inc- Key Brands
6 Company Developments
6.1 FibroGen Inc- Company History
6.2 FibroGen Inc- Latest Developments
7 Financial Analysis
7.1 FibroGen Inc- Income Statements
7.2 FibroGen Inc- Balance Sheet
7.3 FibroGen Inc- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 FibroGen Inc- Direct Competitors
8.2 FibroGen Inc- Competitor Financial Ratios comparison
8.3 FibroGen Inc- Competitor Stock Charts Comparison
8.4 FibroGen Inc- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!